- Conditions
- Burn Related Pain
- Interventions
- TCBR-Pain
- Behavioral
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 137 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 385–408
of 38,032
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Depression, Anxiety
- Interventions
- IDgenetix Neuropsychiatric Test Panel
- Genetic
- Lead sponsor
- AltheaDx
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 220 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015
- U.S. locations
- 1
- States / cities
- Raleigh, North Carolina
- Conditions
- Group B Streptococcus
- Interventions
- Sweeping
- Procedure
- Lead sponsor
- George Washington University
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 120 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2011
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- B-cell Lymphoma
- Interventions
- Bevacizumab, Rituximab, CHOP, Placebo
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 18 Years to 79 Years
- Enrollment
- 787 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2011
- U.S. locations
- 17
- States / cities
- La Jolla, California • Whittier, California • Aurora, Colorado + 14 more
- Conditions
- COPD
- Interventions
- SUN-101 50 mcg BID eFlow (CS) nebulizer, SUN-101 25 mcg BID eFlow (CS) nebulizer, Placebo BID eFlow Closed System (CS) nebulizer
- Drug
- Lead sponsor
- Sunovion Respiratory Development Inc.
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 653 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015
- U.S. locations
- 44
- States / cities
- Anniston, Alabama • Phoenix, Arizona • Tempe, Arizona + 36 more
- Conditions
- Breast Cancer, Primary Hormone Receptor Positive Breast Cancer
- Interventions
- Exercise Treatment, Plant-Based Diet, Physical activity, Nutrition counseling, Replication Exercise Test
- Other
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 43 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2027
- U.S. locations
- 7
- States / cities
- Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more
- Conditions
- Atrial Fibrillation
- Interventions
- Dry bipolar radiofrequency (RF) clamp, Unipolar microwave antenna, Unipolar cryothermic probe, Irrigated unipolar RF antenna, Irrigated bipolar RF clamp, Hi-intensity focused ultrasound wand
- Device
- Lead sponsor
- Maimonides Medical Center
- Other
- Eligibility
- 19 Years to 75 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Brooklyn, New York
- Conditions
- Sickle Cell Disease
- Interventions
- Crovalimab, Placebo
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 12 Years to 55 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 2
- States / cities
- Atlanta, Georgia • New York, New York
- Conditions
- Ketorolac, Joint Fusion
- Interventions
- great toe (1st metatarsophalangeal joint) fusion, IV Ketorolac, Ketorolac Pill, 5/325mg Oxycodone-Acetaminophen, Aspirin 81Mg Ec Tab
- Procedure · Drug
- Lead sponsor
- Rothman Institute Orthopaedics
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 140 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Misophonia
- Interventions
- Acceptance and commitment therapy
- Behavioral
- Lead sponsor
- Utah State University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Logan, Utah
- Conditions
- Partial Thickness Rotator Cuff Tears
- Interventions
- TPX-115, Cryopreserving hyaluronic acid medium, Saline
- Biological · Other · Drug
- Lead sponsor
- Tego Science, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 3
- States / cities
- La Mesa, California • Deerfield Beach, Florida • Chicago, Illinois
- Conditions
- Cytomegalovirus Infection
- Interventions
- mRNA-1647, mRNA-1443, Placebo
- Biological · Other
- Lead sponsor
- ModernaTX, Inc.
- Industry
- Eligibility
- 18 Years to 49 Years
- Enrollment
- 181 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2020
- U.S. locations
- 4
- States / cities
- Hollywood, Florida • Meridian, Idaho • Peoria, Illinois + 1 more
- Conditions
- Autistic Disorder
- Interventions
- N-Acetyl Cysteine, Placebo - sugar pill
- Drug · Other
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 3 Years to 12 Years
- Enrollment
- 43 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Vascular Ehlers-Danlos Syndrome
- Interventions
- ACER-002 (celiprolol) 200 mg BID, Placebo BID
- Drug
- Lead sponsor
- Acer Therapeutics Inc.
- Industry
- Eligibility
- 15 Years to 64 Years
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2029
- U.S. locations
- 1
- States / cities
- Culver City, California
- Conditions
- Generalized Myasthenia Gravis
- Interventions
- Rozanolixizumab, Placebo
- Drug · Other
- Lead sponsor
- UCB Biopharma SRL
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 30
- States / cities
- Phoenix, Arizona • Scottsdale, Arizona • Los Angeles, California + 23 more
- Conditions
- Diaper Rash, UTI, Depressive Symptoms, Stress
- Interventions
- Diapers, Resources of diaper banks
- Other
- Lead sponsor
- Boston Medical Center
- Other
- Eligibility
- 2 Days to 9 Months
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Influenza
- Interventions
- Quadrivalent VLP Vaccine, Comparator TIV
- Biological
- Lead sponsor
- Novavax
- Industry
- Eligibility
- 18 Years to 49 Years
- Enrollment
- 400 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2015
- U.S. locations
- 5
- States / cities
- Anaheim, California • Miami, Florida • Lenexa, Kansas + 2 more
- Conditions
- Erectile Dysfunction
- Interventions
- placebo, avanafil
- Drug
- Lead sponsor
- VIVUS LLC
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 646 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 41
- States / cities
- Birmingham, Alabama • Homewood, Alabama • Tucson, Arizona + 33 more
- Conditions
- Male Sexual Dysfunction, Ejaculatory Dysfunction
- Interventions
- BTL Emsella Chair
- Device
- Lead sponsor
- Corewell Health East
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 117 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2028
- U.S. locations
- 1
- States / cities
- Royal Oak, Michigan
- Conditions
- Generalized Anxiety Disorder (GAD)
- Interventions
- ABBV-932, Placebo for ABBV-932, Antidepressant Therapy (ADT)
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 315 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 49
- States / cities
- Huntsville, Alabama • Phoenix, Arizona • Tucson, Arizona + 43 more
- Conditions
- Hyperhidrosis, Palmar Hyperhidrosis
- Interventions
- Dexmecamylamine HCl, Placebo
- Drug · Other
- Lead sponsor
- Atacama Therapeutics
- Industry
- Eligibility
- 16 Years and older
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 1
- States / cities
- Norfolk, Virginia
- Conditions
- Primary Open Angle Glaucoma
- Interventions
- Dietary supplements - Nicotinamide and Pyruvate, Placebo
- Drug
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 35 Years to 85 Years
- Enrollment
- 250 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2028
- U.S. locations
- 3
- States / cities
- Palo Alto, California • New York, New York
- Conditions
- Eosinophilic Esophagitis
- Interventions
- Fluticasone, Placebo
- Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2010
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Orthostatic Hypotension
- Interventions
- Physical Therapy
- Other
- Lead sponsor
- University of Texas at Austin
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022
- U.S. locations
- 1
- States / cities
- Austin, Texas